US Stock MarketDetailed Quotes

AMLX Amylyx Pharmaceuticals

Watchlist
  • 3.660
  • -0.210-5.43%
Close Mar 28 16:00 ET
  • 3.660
  • 0.0000.00%
Post 18:34 ET
324.29MMarket Cap-0.83P/E (TTM)

Amylyx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1,506.55%-167.65M
-535.45%-59.01M
-704.22%-41.57M
-873.38%-66.58M
90.36%-489K
106.63%11.92M
127.27%13.55M
88.00%-5.17M
118.53%8.61M
87.52%-5.07M
Net income from continuing operations
-712.42%-301.74M
-893.62%-37.55M
-447.98%-72.7M
-429.35%-72.7M
-7,652.00%-118.79M
124.84%49.27M
111.08%4.73M
138.87%20.89M
140.83%22.07M
103.29%1.57M
Depreciation and amortization
-16.91%904K
-46.84%160K
-26.82%221K
-25.98%208K
54.41%315K
123.41%1.09M
65.38%301K
83.03%302K
167.62%281K
482.86%204K
Other non cash items
--37.16M
--131K
--36.2M
--805K
--22K
----
----
----
----
----
Change In working capital
30.20%-45.83M
-1,815.03%-26.7M
68.89%-10.6M
59.95%-8.7M
101.43%164K
-3,901.28%-65.66M
113.65%1.56M
-770.70%-34.06M
-1,241.59%-21.71M
-511.02%-11.45M
-Change in receivables
260.05%39.6M
108.86%980K
-53.71%2.24M
200.22%16.56M
1,092.74%19.82M
-66.97%-24.74M
24.31%-11.07M
2,719.46%4.85M
-137,625.00%-16.53M
-199,500.00%-2M
-Change in inventory
87.35%-9.25M
--0
--0
--0
30.44%-9.25M
-648.58%-73.13M
-187.65%-26.48M
-2,388.81%-14.01M
---19.33M
---13.3M
-Change in prepaid assets
254.62%4.99M
-111.62%-508K
161.15%3.84M
140.47%3.76M
27.00%-2.1M
38.21%-3.23M
286.59%4.37M
-634.75%-6.28M
86.86%1.56M
41.06%-2.88M
-Change in payables and accrued expense
-310.55%-78.91M
-168.11%-24.92M
10.48%-16.6M
-329.20%-28.96M
-224.14%-8.43M
34.30%37.48M
146.96%36.59M
-507.45%-18.54M
1,524.29%12.64M
-12.52%6.79M
-Change in other current assets
----
----
10.81%492K
11.69%497K
55.28%677K
----
----
6.22%444K
6.97%445K
631.71%436K
-Change in other current liabilities
-10.53%-2.26M
-10.15%-586K
-10.60%-574K
-10.82%-553K
-10.59%-543K
-122.57%-2.04M
-10.60%-532K
-64.24%-519K
-326.50%-499K
-16,266.67%-491K
Cash from discontinued investing activities
Operating cash flow
-1,506.55%-167.65M
-535.45%-59.01M
-704.22%-41.57M
-873.38%-66.58M
90.36%-489K
106.63%11.92M
127.27%13.55M
88.00%-5.17M
118.53%8.61M
87.52%-5.07M
Investing cash flow
Cash flow from continuing investing activities
-17.81%75.65M
210.54%64.98M
135.91%38.82M
-123.50%-28.96M
-98.54%819K
138.52%92.05M
109.17%20.93M
-228.61%-108.09M
2,661.59%123.22M
156.38%55.99M
Net PPE purchase and sale
87.35%-157K
94.38%-20K
105.32%19K
67.99%-89K
73.20%-67K
50.87%-1.24M
42.58%-356K
22.22%-357K
74.84%-278K
26.90%-250K
Net investment purchase and sale
20.07%112.01M
205.44%65M
169.62%75M
-123.38%-28.87M
-98.42%886K
139.45%93.29M
109.35%21.28M
-227.49%-107.73M
2,118.43%123.5M
156.83%56.24M
Net other investing changes
---36.2M
--0
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-17.81%75.65M
210.54%64.98M
135.91%38.82M
-123.50%-28.96M
-98.54%819K
138.52%92.05M
109.17%20.93M
-228.61%-108.09M
2,661.59%123.22M
156.38%55.99M
Financing cash flow
Cash flow from continuing financing activities
-90.18%348K
-52.17%110K
-91.00%80K
-98.05%27K
-87.40%131K
-99.18%3.54M
-99.90%230K
889K
267.15%1.38M
-99.48%1.04M
Proceeds from stock option exercised by employees
-69.52%2.13M
-57.35%148K
-50.10%491K
-97.79%47K
-59.14%1.45M
219.51%6.99M
-82.12%347K
--984K
756.45%2.12M
--3.54M
Net other financing activities
48.30%-1.78M
67.52%-38K
-332.63%-411K
97.30%-20K
47.38%-1.32M
-21.22%-3.45M
91.20%-117K
---95K
31.23%-740K
-465.38%-2.5M
Cash from discontinued financing activities
Financing cash flow
-90.18%348K
-52.17%110K
-91.00%80K
-98.05%27K
-87.40%131K
-99.18%3.54M
-99.90%230K
--889K
267.15%1.38M
-99.48%1.04M
Net cash flow
Beginning cash position
170.25%170.92M
-46.11%73.28M
-69.53%75.72M
48.57%171.27M
170.25%170.92M
25.54%63.25M
25.38%135.98M
266.17%248.48M
4.02%115.28M
25.54%63.25M
Current changes in cash
-185.24%-91.65M
-82.48%6.08M
97.62%-2.67M
-171.70%-95.51M
-99.11%461K
731.52%107.52M
175.92%34.71M
-374.32%-112.37M
411.05%133.22M
-14.13%51.96M
Effect of exchange rate changes
-373.75%-438K
-321.52%-525K
276.12%236K
-116.67%-39K
-246.67%-110K
346.15%160K
-53.25%237K
63.69%-134K
86.67%-18K
210.29%75K
End cash Position
-53.87%78.84M
-53.87%78.84M
-46.11%73.28M
-69.53%75.72M
48.57%171.27M
170.25%170.92M
170.25%170.92M
25.38%135.98M
266.17%248.48M
4.02%115.28M
Free cash flow
-1,671.49%-167.8M
-547.35%-59.03M
-651.92%-41.55M
-900.25%-66.67M
89.55%-556K
105.85%10.68M
126.22%13.2M
87.31%-5.53M
117.51%8.33M
87.01%-5.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1,506.55%-167.65M-535.45%-59.01M-704.22%-41.57M-873.38%-66.58M90.36%-489K106.63%11.92M127.27%13.55M88.00%-5.17M118.53%8.61M87.52%-5.07M
Net income from continuing operations -712.42%-301.74M-893.62%-37.55M-447.98%-72.7M-429.35%-72.7M-7,652.00%-118.79M124.84%49.27M111.08%4.73M138.87%20.89M140.83%22.07M103.29%1.57M
Depreciation and amortization -16.91%904K-46.84%160K-26.82%221K-25.98%208K54.41%315K123.41%1.09M65.38%301K83.03%302K167.62%281K482.86%204K
Other non cash items --37.16M--131K--36.2M--805K--22K--------------------
Change In working capital 30.20%-45.83M-1,815.03%-26.7M68.89%-10.6M59.95%-8.7M101.43%164K-3,901.28%-65.66M113.65%1.56M-770.70%-34.06M-1,241.59%-21.71M-511.02%-11.45M
-Change in receivables 260.05%39.6M108.86%980K-53.71%2.24M200.22%16.56M1,092.74%19.82M-66.97%-24.74M24.31%-11.07M2,719.46%4.85M-137,625.00%-16.53M-199,500.00%-2M
-Change in inventory 87.35%-9.25M--0--0--030.44%-9.25M-648.58%-73.13M-187.65%-26.48M-2,388.81%-14.01M---19.33M---13.3M
-Change in prepaid assets 254.62%4.99M-111.62%-508K161.15%3.84M140.47%3.76M27.00%-2.1M38.21%-3.23M286.59%4.37M-634.75%-6.28M86.86%1.56M41.06%-2.88M
-Change in payables and accrued expense -310.55%-78.91M-168.11%-24.92M10.48%-16.6M-329.20%-28.96M-224.14%-8.43M34.30%37.48M146.96%36.59M-507.45%-18.54M1,524.29%12.64M-12.52%6.79M
-Change in other current assets --------10.81%492K11.69%497K55.28%677K--------6.22%444K6.97%445K631.71%436K
-Change in other current liabilities -10.53%-2.26M-10.15%-586K-10.60%-574K-10.82%-553K-10.59%-543K-122.57%-2.04M-10.60%-532K-64.24%-519K-326.50%-499K-16,266.67%-491K
Cash from discontinued investing activities
Operating cash flow -1,506.55%-167.65M-535.45%-59.01M-704.22%-41.57M-873.38%-66.58M90.36%-489K106.63%11.92M127.27%13.55M88.00%-5.17M118.53%8.61M87.52%-5.07M
Investing cash flow
Cash flow from continuing investing activities -17.81%75.65M210.54%64.98M135.91%38.82M-123.50%-28.96M-98.54%819K138.52%92.05M109.17%20.93M-228.61%-108.09M2,661.59%123.22M156.38%55.99M
Net PPE purchase and sale 87.35%-157K94.38%-20K105.32%19K67.99%-89K73.20%-67K50.87%-1.24M42.58%-356K22.22%-357K74.84%-278K26.90%-250K
Net investment purchase and sale 20.07%112.01M205.44%65M169.62%75M-123.38%-28.87M-98.42%886K139.45%93.29M109.35%21.28M-227.49%-107.73M2,118.43%123.5M156.83%56.24M
Net other investing changes ---36.2M--0--------------------------------
Cash from discontinued investing activities
Investing cash flow -17.81%75.65M210.54%64.98M135.91%38.82M-123.50%-28.96M-98.54%819K138.52%92.05M109.17%20.93M-228.61%-108.09M2,661.59%123.22M156.38%55.99M
Financing cash flow
Cash flow from continuing financing activities -90.18%348K-52.17%110K-91.00%80K-98.05%27K-87.40%131K-99.18%3.54M-99.90%230K889K267.15%1.38M-99.48%1.04M
Proceeds from stock option exercised by employees -69.52%2.13M-57.35%148K-50.10%491K-97.79%47K-59.14%1.45M219.51%6.99M-82.12%347K--984K756.45%2.12M--3.54M
Net other financing activities 48.30%-1.78M67.52%-38K-332.63%-411K97.30%-20K47.38%-1.32M-21.22%-3.45M91.20%-117K---95K31.23%-740K-465.38%-2.5M
Cash from discontinued financing activities
Financing cash flow -90.18%348K-52.17%110K-91.00%80K-98.05%27K-87.40%131K-99.18%3.54M-99.90%230K--889K267.15%1.38M-99.48%1.04M
Net cash flow
Beginning cash position 170.25%170.92M-46.11%73.28M-69.53%75.72M48.57%171.27M170.25%170.92M25.54%63.25M25.38%135.98M266.17%248.48M4.02%115.28M25.54%63.25M
Current changes in cash -185.24%-91.65M-82.48%6.08M97.62%-2.67M-171.70%-95.51M-99.11%461K731.52%107.52M175.92%34.71M-374.32%-112.37M411.05%133.22M-14.13%51.96M
Effect of exchange rate changes -373.75%-438K-321.52%-525K276.12%236K-116.67%-39K-246.67%-110K346.15%160K-53.25%237K63.69%-134K86.67%-18K210.29%75K
End cash Position -53.87%78.84M-53.87%78.84M-46.11%73.28M-69.53%75.72M48.57%171.27M170.25%170.92M170.25%170.92M25.38%135.98M266.17%248.48M4.02%115.28M
Free cash flow -1,671.49%-167.8M-547.35%-59.03M-651.92%-41.55M-900.25%-66.67M89.55%-556K105.85%10.68M126.22%13.2M87.31%-5.53M117.51%8.33M87.01%-5.32M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Petroleo Brasileiro SA Petrobras
PBR
14.380
Vale SA
VALE
10.040
Ecopetrol
EC
10.220
4
Taylor Morrison Home
TMHC
59.980
5
KB Home
KBH
57.730
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call